Top companies in United States by Price to Sales Ratio (P/S)

This ranking features the top 3,438 companies in United States ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 53,783.56, for January 15, 2025.

United States

All sectors

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Inhibikase Therapeutics, Inc. 1 IKT	184,503,984.00	Jan. 14, 2025	USD 2.66	NA	United States
2	Gatos Silver, Inc. 2 GATO	73,737.44	Jan. 14, 2025	USD 14.86	5.02%	United States
3	Benitec Biopharma Inc. 3 BNTC	40,164.37	Jan. 14, 2025	USD 10.38	-0.10%	United States
4	Greenwich LifeSciences, Inc. 4 GLSI	29,258.97	Jan. 14, 2025	USD 12.06	-1.63%	United States
5	DatChat, Inc. 5 DATS	28,515.59	Jan. 14, 2025	USD 4.88	-9.96%	United States
6	Forte Biosciences, Inc. 6 FBRX	15,578.39	Jan. 14, 2025	USD 14.62	-8.62%	United States
7	Immix Biopharma, Inc. 7 IMMX	11,499.83	Jan. 14, 2025	USD 2.00	-5.66%	United States
8	Bullfrog AI Holdings, Inc. Common Stock 8 BFRG	10,613.47	Jan. 14, 2025	USD 2.10	-0.47%	United States
9	Cadrenal Therapeutics, Inc. Common Stock 9 CVKD	10,296.97	Jan. 14, 2025	USD 15.99	NA	United States
10	Revolution Medicines, Inc. 10 RVMD	9,919.66	Jan. 14, 2025	USD 39.83	-6.44%	United States
11	Allogene Therapeutics, Inc. 11 ALLO	9,362.10	Jan. 14, 2025	USD 1.92	-1.54%	United States
12	Viking Therapeutics, Inc. 12 VKTX	8,672.07	Jan. 14, 2025	USD 33.93	-12.73%	United States
13	Altimmune, Inc. 13 ALT	8,521.27	Jan. 14, 2025	USD 6.23	-8.11%	United States
14	NRx Pharmaceuticals, Inc. 14 NRXP	7,709.99	Jan. 14, 2025	USD 5.10	3.87%	United States
15	Joby Aviation, Inc. 15 JOBY	5,403.03	Jan. 14, 2025	USD 7.86	-1.26%	United States
16	Akero Therapeutics, Inc. 16 AKRO	5,375.03	Jan. 14, 2025	USD 21.87	-3.36%	United States
17	NET Power Inc. 17 NPWR	5,297.49	Jan. 14, 2025	USD 8.80	-3.93%	United States
18	Rezolute, Inc. 18 RZLT	4,715.37	Jan. 14, 2025	USD 4.72	-0.63%	United States
19	Viridian Therapeutics, Inc. 19 VRDN	4,422.27	Jan. 14, 2025	USD 16.86	-5.12%	United States
20	Eve Holding, Inc. 20 EVEX	4,146.45	Jan. 14, 2025	USD 4.20	-3.45%	United States
21	Gaxos.ai Inc. 21 GXAI	3,974.19	Jan. 14, 2025	USD 1.71	2.40%	United States
22	Context Therapeutics Inc. 22 CNTX	3,918.10	Jan. 14, 2025	USD 0.99	-3.87%	United States
23	Tenax Therapeutics, Inc. 23 TENX	3,785.72	Jan. 14, 2025	USD 6.43	4.38%	United States
24	VirnetX Holding Corp 24 VHC	3,579.95	Jan. 14, 2025	USD 7.68	6.22%	United States
25	Checkpoint Therapeutics, Inc. 25 CKPT	3,293.60	Jan. 14, 2025	USD 3.17	-0.94%	United States
26	Crinetics Pharmaceuticals, Inc. 26 CRNX	3,179.32	Jan. 14, 2025	USD 35.62	-8.62%	United States
27	89bio, Inc. 27 ETNB	3,155.62	Jan. 14, 2025	USD 6.28	-0.47%	United States
28	INmune Bio, Inc. 28 INMB	3,143.74	Jan. 14, 2025	USD 5.96	-8.87%	United States
29	Trump Media & Technology Group Corp. 29 DJT	2,533.08	Jan. 14, 2025	USD 39.35	-8.30%	United States
30	Quantum Computing, Inc. 30 QUBT	2,480.95	Jan. 14, 2025	USD 7.43	13.96%	United States
31	AST SpaceMobile, Inc. 31 ASTS	2,373.51	Jan. 14, 2025	USD 20.48	-2.80%	United States
32	NextDecade Corporation 32 NEXT	2,302.57	Jan. 14, 2025	USD 8.05	3.34%	United States
33	Sera Prognostics, Inc. 33 SERA	2,288.63	Jan. 14, 2025	USD 6.37	0.63%	United States
34	Enliven Therapeutics, Inc. 34 ELVN	2,271.95	Jan. 14, 2025	USD 20.46	-7.29%	United States
35	Immunovant, Inc. 35 IMVT	2,238.96	Jan. 14, 2025	USD 22.88	0.57%	United States
36	Lightwave Logic, Inc. 36 LWLG	2,108.20	Jan. 14, 2025	USD 1.95	2.63%	United States
37	Quince Therapeutics, Inc. 37 QNCX	2,090.08	Jan. 14, 2025	USD 1.71	-1.16%	United States
38	Trevi Therapeutics, Inc. 38 TRVI	1,995.50	Jan. 14, 2025	USD 3.93	-1.50%	United States
39	Chimerix, Inc. 39 CMRX	1,906.98	Jan. 14, 2025	USD 3.37	1.81%	United States
40	Celcuity Inc. 40 CELC	1,702.50	Jan. 14, 2025	USD 10.53	-2.95%	United States
41	Cytokinetics, Incorporated 41 CYTK	1,658.21	Jan. 14, 2025	USD 45.23	-3.17%	United States
42	Tyra Biosciences, Inc. 42 TYRA	1,606.80	Jan. 14, 2025	USD 15.94	5.56%	United States
43	Corvus Pharmaceuticals, Inc. 43 CRVS	1,332.16	Jan. 14, 2025	USD 5.10	-1.92%	United States
44	Acelyrin, Inc. 44 SLRN	1,269.18	Jan. 14, 2025	USD 2.10	-2.33%	United States
45	Spyre Therapeutics, Inc. 45 SYRE	1,203.69	Jan. 14, 2025	USD 20.80	-3.48%	United States
46	Edgewise Therapeutics, Inc. 46 EWTX	1,157.12	Jan. 14, 2025	USD 27.52	8.65%	United States
47	Structure Therapeutics Inc. 47 GPCR	1,092.72	Jan. 14, 2025	USD 25.38	0.87%	United States
48	Gain Therapeutics, Inc. 48 GANX	851.42	Jan. 14, 2025	USD 2.08	-5.02%	United States
49	Keros Therapeutics, Inc. 49 KROS	776.55	Jan. 14, 2025	USD 12.48	-2.65%	United States
50	Praxis Precision Medicines, Inc. 50 PRAX	764.56	Jan. 14, 2025	USD 65.84	2.84%	United States

1 2 3 4 … 69

Frequently Asked Questions

Which company in United States has the highest Price to Sales Ratio (P/S) ?

The company in United States with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 184,503,984.00.
Which company in United States has the lowest Price to Sales Ratio (P/S) ?

The company in United States with the lowest Price to Sales Ratio (P/S) is LM Funding America, Inc. (NasdaqCM: LMFA) at 0.00.

What are the top 10 companies in United States by Price to Sales Ratio (P/S) ?

The top 10 companies in United States by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Gatos Silver, Inc., Benitec Biopharma Inc., Greenwich LifeSciences, Inc., DatChat, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Cadrenal Therapeutics, Inc. Common Stock and Revolution Medicines, Inc..
What are the bottom 10 companies in United States by Price to Sales Ratio (P/S) ?

The bottom 10 companies in United States by Price to Sales Ratio (P/S) are LM Funding America, Inc., Comtech Telecommunications Corp., Tennessee Valley Authority PARRS D 2028, Air Industries Group, Snail, Inc. Class A Common Stock, Streamline Health Solutions, Inc., Ispire Technology Inc., Kopin Corporation, Lipella Pharmaceuticals Inc. and SigmaTron International, Inc..